Bionoid Pharma Stock Market Value
| BINP Stock | USD 0.23 0.00 0.00% |
| Symbol | Bionoid |
Bionoid Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bionoid Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bionoid Pharma.
| 06/07/2024 |
| 12/04/2024 |
If you would invest 0.00 in Bionoid Pharma on June 7, 2024 and sell it all today you would earn a total of 0.00 from holding Bionoid Pharma or generate 0.0% return on investment in Bionoid Pharma over 180 days. Bionoid Pharma Inc. engages in the hemp cultivation business More
Bionoid Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bionoid Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bionoid Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0651 | |||
| Maximum Drawdown | 109.09 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 25.0 |
Bionoid Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bionoid Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bionoid Pharma's standard deviation. In reality, there are many statistical measures that can use Bionoid Pharma historical prices to predict the future Bionoid Pharma's volatility.| Risk Adjusted Performance | 0.0637 | |||
| Jensen Alpha | 1.3 | |||
| Total Risk Alpha | (1.28) | |||
| Treynor Ratio | 1.73 |
Bionoid Pharma Backtested Returns
Bionoid Pharma is out of control given 3 months investment horizon. Bionoid Pharma secures Sharpe Ratio (or Efficiency) of 0.0725, which signifies that the company had a 0.0725% return per unit of risk over the last 3 months. We were able to interpolate nineteen different technical indicators, which can help you to evaluate if expected returns of 1.46% are justified by taking the suggested risk. Use Bionoid Pharma Mean Deviation of 7.99, standard deviation of 19.65, and Risk Adjusted Performance of 0.0637 to evaluate company specific risk that cannot be diversified away. Bionoid Pharma holds a performance score of 5 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.8, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bionoid Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bionoid Pharma is expected to be smaller as well. Use Bionoid Pharma variance, potential upside, as well as the relationship between the Potential Upside and day typical price , to analyze future returns on Bionoid Pharma.
Auto-correlation | 0.01 |
Virtually no predictability
Bionoid Pharma has virtually no predictability. Overlapping area represents the amount of predictability between Bionoid Pharma time series from 7th of June 2024 to 5th of September 2024 and 5th of September 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bionoid Pharma price movement. The serial correlation of 0.01 indicates that just 1.0% of current Bionoid Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.01 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Bionoid Pharma lagged returns against current returns
Autocorrelation, which is Bionoid Pharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bionoid Pharma's pink sheet expected returns. We can calculate the autocorrelation of Bionoid Pharma returns to help us make a trade decision. For example, suppose you find that Bionoid Pharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bionoid Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bionoid Pharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bionoid Pharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bionoid Pharma pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Bionoid Pharma Lagged Returns
When evaluating Bionoid Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bionoid Pharma pink sheet have on its future price. Bionoid Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bionoid Pharma autocorrelation shows the relationship between Bionoid Pharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Bionoid Pharma.
Regressed Prices |
| Timeline |
Pair Trading with Bionoid Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionoid Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Bionoid Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionoid Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionoid Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionoid Pharma to buy it.
The correlation of Bionoid Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bionoid Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bionoid Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bionoid Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Bionoid Pink Sheet Analysis
When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.